This inventor holds 1 USPTO granted patent. Top assignee: South African Inventions Development Corporation. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovative Contributions of Donald A. Hendry
Introduction
Donald A. Hendry is a notable inventor based in Makhanda, South Africa. He has made significant contributions to the field of immunization through his innovative patent. His work focuses on developing immunizing agents that enhance the effectiveness of vaccines.
Latest Patents
Hendry holds a patent for an "Adjuvant for Immunization." This invention provides an immunizing agent or preparation for parenteral administration. It comprises particles of coalesced and covalently interlinked physiologically compatible proteinaceous molecules. Entrapped within these particles is an immunogen that is gradually released through proteolysis. This release mechanism ensures that the immunogen is of sufficient size to elicit an immune response to its characteristic immunogenic determinants. The proteinaceous molecules are preferably homotypic for the animal to be immunized, and the particles carrying the immunogenic determinants are crosslinked to these proteinaceous molecules. He has 1 patent to his name.
Career Highlights
Hendry is associated with the South African Inventions Development Corporation, where he continues to work on innovative solutions in the field of immunization. His dedication to research and development has positioned him as a key figure in advancing vaccine technology.
Collaborations
Hendry collaborates with John F. Newman, contributing to the development of innovative immunization strategies. Their partnership exemplifies the importance of teamwork in the field of scientific research.
Conclusion
Donald A. Hendry's contributions to immunization through his patented invention highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile